Lars Thunberg

Lars Thunberg discloses dealings in 2 companies, chiefly Panion Animal Health and Combigene AB. In total, 9 filings cover trades dated from 2 October 2018 to 3 April 2020.

On the open market, the record shows 4 purchases worth €203k and 5 sales worth €246k. The net balance comes to €42k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2020 alone, the filings show 1 purchase and no sales.

A typical purchase (the median) is worth €20k. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

On 6 April 2020 came the latest disclosure, an open-market purchase for €11k in Combigene AB. Filings reach the Finansinspektionen feed a median of 2 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.